Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Hironobu Ihn(Kumamoto University), Kunihiko Tamaki(The University of Tokyo), Shinichi Sato(University of Tokyo Hospital), Kanako Kikuchi(The University of Tokyo), Kenichi Yamane(The University of Tokyo), Masahide Kubo(The University of Tokyo), Manabu Fujimoto(Osaka Gakuin University), Yoshinao Soma(Tokyo Metropolitan Police Hospital), Norihito Yazawa(The University of Tokyo)
PubMed
March 1, 2000
Cited by 44
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438